A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders
Clinical trial NCT04154488 · COMPLETED
Trial details
- NCT number
- NCT04154488
- Sponsor
- X4 Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-16
- Primary completion
- 2024-08-27
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.